Class 4 Medicines Defect Information: Atnahs Pharma UK Limited, Naprosyn Tablets (all strengths), Naprosyn EC 250mg Gastro-Resistant Tablets
Atnahs Pharma UK Limited have identified missing information on the PIL of certain batches
Further information and advice for healthcare professionals can be found on theMHRA website (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 3, 2022 Category: Drugs & Pharmacology Source Type: news
RPS Scotland publishes Pharmacy 2030
The Royal Pharmaceutical Society (RPS) has today published Pharmacy 2030, which outlines an exciting new vision for the future of pharmacy in Scotland.
It describes a future in which pharmacy teams w (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 2, 2022 Category: Drugs & Pharmacology Source Type: news
Medicine Supply Notification: Aspirin 150mg and 300mg suppositories
The Department of Health and Social Care has issued a supply notification. Aspirin 150mg and 300mg suppositories are out of stock until mid-April 2022 which will require clinicians reviewing all patie (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 2, 2022 Category: Drugs & Pharmacology Source Type: news
Mandatory vaccinations being reconsidered in England
NHS England has published an update following news that the Government is reconsidering legislation requiring vaccination as a condition of deployment, which was due to come into effect from April 1 2 (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 1, 2022 Category: Drugs & Pharmacology Source Type: news
Update: Vaccination as a condition of deployment (VCOD) for all healthcare workers
NHS England and NHS Improvement has issued a letter providing an update on the vaccination as a condition of deployment (VCOD) for all healthcare workers.
The Government passed legislation requiring (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 1, 2022 Category: Drugs & Pharmacology Source Type: news
COVID-19 Therapeutic Alerts
Antivirals Or Neutralising Monoclonal Antibodies For Non-Hospitalised Patients With Covid-19
The published policy, providing access to monoclonal antibodies or antivirals as treatment options for non (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - January 28, 2022 Category: Drugs & Pharmacology Source Type: news
HEE launches new independent prescriber training for pharmacists
Health Education England has announced new funded Independent Prescriber courses for pharmacists, which will be available before March 2022.
There are places available for both Independent Prescribin (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - January 27, 2022 Category: Drugs & Pharmacology Source Type: news
Medicine Supply Notification: Paracetamol 120mg and 240mg suppositories
The Department of Health and Social Care has issued a supply notification. Paracetamol 120mg and 240mg suppositories are out of stock until w/c 21st February 2022. Paracetamol 125mg and 250mg supposit (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - January 27, 2022 Category: Drugs & Pharmacology Source Type: news
Drug Monitoring Checker now available through MedicinesComplete
Pharmaceutical Press, the Royal Pharmaceutical Society’s knowledge business, is announcing the release of Drug Monitoring Checker. Available online through MedicinesComplete, Drug Monitoring Che (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - January 26, 2022 Category: Drugs & Pharmacology Source Type: news
Health, Social Care and Sport Committee Inquiry into Alternative pathways into Primary Care
The Royal Pharmaceutical Society (RPS) in Scotland today welcomes the Health, Social Care and Sport Committee inquiry into alternative pathways into primary care.
Pharmacists provide face to face hea (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - January 24, 2022 Category: Drugs & Pharmacology Source Type: news
Helping you put your inclusion and wellbeing pledge into action
We’ve created a set of ideas to help individuals, teams and organisation put our inclusion and wellbeing pledge into action.
They range from practical short-term steps like knowing where to sig (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - January 24, 2022 Category: Drugs & Pharmacology Source Type: news
Class 2 Medicines Recall: SANTEN Oy (trading as Santen UK Limited) IKERVIS 1 mg/mL eye drops, emulsion
SANTEN Oy (trading as Santen UK Limited) are recalling certain batches of products as a precautionary measure due to detection of particles/crystals of the active pharmaceutical ingredient ciclosporin (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - January 19, 2022 Category: Drugs & Pharmacology Source Type: news
Challenging barriers for pharmacists with disabilities
We’ve launched a campaign to challenge barriers to working in pharmacy for those with disabilities as part of our ongoinginclusion and diversity strategy.
Our profession-wide survey on inclusi (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - January 19, 2022 Category: Drugs & Pharmacology Source Type: news
